Corrigendum to "HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption" [J Virus Erad 9 (2) (June 2023) 100331]
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_0c5fa81f6fac433b818b23a24f9a9a19 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Eunice Akinyi Okumu |e author |
| 700 | 1 | 0 | |a Gail E. Henderson |e author |
| 700 | 1 | 0 | |a Carol Golin |e author |
| 700 | 1 | 0 | |a Kriste Kuczynski |e author |
| 700 | 1 | 0 | |a Nuchanart Q. Ormsby |e author |
| 700 | 1 | 0 | |a Holly L. Peay |e author |
| 245 | 0 | 0 | |a Corrigendum to "HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption" [J Virus Erad 9 (2) (June 2023) 100331] |
| 260 | |b Elsevier, |c 2023-09-01T00:00:00Z. | ||
| 500 | |a 2055-6640 | ||
| 500 | |a 10.1016/j.jve.2023.100340 | ||
| 546 | |a EN | ||
| 690 | |a Microbiology | ||
| 690 | |a QR1-502 | ||
| 690 | |a Public aspects of medicine | ||
| 690 | |a RA1-1270 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Virus Eradication, Vol 9, Iss 3, Pp 100340- (2023) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2055664023000262 | |
| 787 | 0 | |n https://doaj.org/toc/2055-6640 | |
| 856 | 4 | 1 | |u https://doaj.org/article/0c5fa81f6fac433b818b23a24f9a9a19 |z Connect to this object online. |